NeuroGen
NeuroGen Brain & Spine Institute is a Navi Mumbai-based specialty hospital founded in 2008 that combines autologous bone marrow-derived cell therapy with neurorehabilitation to treat otherwise incurable neurological conditions including autism, cerebral palsy, muscular dystrophy, spinal cord injury, stroke, and ALS, serving 16,000+ patients from 70+ countries.
- Company typePrivate
- Founded2008
- HeadquartersMumbai, India
- Headcount51–100
- GTM typeB2C
- OfferingServices
What NeuroGen does
NeuroGen Brain & Spine Institute is a privately held, for-profit medical facility founded in 2008 in Navi Mumbai, India, specializing in regenerative medicine and neurorehabilitation for neurological disorders that conventional medicine offers limited options for. The institute treats autism spectrum disorder, cerebral palsy, muscular dystrophy, spinal cord injury, intellectual disability, brain stroke, traumatic brain injury, motor neuron disease/ALS, and other neurological conditions. Its core protocol, branded NeuroRegenerative Rehabilitation Therapy (NRRT), combines an autologous bone marrow mononuclear cell grafting procedure (performed in the same surgical sitting within the hospital, in line with Ministry of Health and Family Welfare directives under section 33P of the Drugs and Cosmetics Act 1940) with intensive, structured neurorehabilitation delivered under one roof. The institute uses PET CT imaging for outcome measurement and operates with a multidisciplinary team covering medical services, cellular laboratory work, and neurorehabilitation, led by founder Dr. Alok Sharma.
The business model is a hybrid of specialty clinical services and medical tourism. Revenue is generated primarily from individually priced, quote-based patient treatment services delivered at the single Navi Mumbai facility, augmented by a professional-services training stream via the Regenerative Neuro-Rehabilitation Fellowship Program. Patient acquisition is sales-led and content-driven, relying on multilingual consultation videos (Hindi, Marathi, Gujarati), scientific publications, 24 published books, patient testimonials, and a dedicated International Patient Services division that coordinates travel and stay for patients from 70+ countries. The institute reports 16,000+ cumulative patients treated, 112 peer-reviewed scientific publications, 24 books, and headcount of approximately 200 professionals across medical, rehabilitation, research, and support functions. Quality credentials include renewed ISO, GLP, and GMP certifications (2018) and multiple international awards including the Rose of Paracelsus Award (EMA, Cannes 2016) and Best Hospital (Europe Business Assembly, Dubai 2017).
Operating performance is indicated by an expanding patient base growing from 9,500+ to 16,000+ cumulative, a publication count rising from 89-99 to 112, and a leadership team that has grown to include dedicated deputy directors across medical, laboratory, and rehabilitation functions plus a Head of Administration, HR, and Quality Assurance. No external funding rounds, M&A activity, or geographic expansion beyond a single facility are disclosed. Pricing is not publicly disclosed, and revenue is not reported.
NeuroGen firmographics
Firmographics- Name
- NeuroGen
- Legal name
- NeuroGen Brain & Spine Institute
- Website
- https://neurogen.in
- Company type
- Private
- Founded year
- 2008
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- NeuroGen Brain & Spine Institute is a Navi Mumbai-based specialty hospital founded in 2008 that combines autologous bone marrow-derived cell therapy with neurorehabilitation to treat otherwise incurable neurological conditions including autism, cerebral palsy, muscular dystrophy, spinal cord injury, stroke, and ALS, serving 16,000+ patients from 70+ countries.
- Ownership category
- akta.pro rank
NeuroGen industry classification
Industry- Product category
- Neurological Rehabilitation Services
- NAICS
- Offices of Physical, Occupational and Speech Therapists, and Audiologists (621340)
- SIC
- Services-Health Services (8000), Services-Offices & Clinics Of Doctors Of Medicine (8011)
- akta.pro primary industry
- Neurorehabilitation Centers (HLAFAFAH)
- akta.pro secondary industry
- Neurologic Rehabilitation Centers (Stroke/TBI/SCI/MS/Parkinson’s) (HLADAJAH)
Keywords
Where NeuroGen is headquartered
LocationHeadquarters
- HQ city
- Mumbai
- HQ country
- India
- HQ region
- Asia
Offices1 record
Markets served
NeuroGen business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Patient Treatment Services: Revenue generated from providing regenerative medicine treatments and neurorehabilitation services to patients with neurological disorders. Treatment is provided at their facility in Navi Mumbai, India, with services for both domestic and international patients.
- Fellowship Program: Training and fellowship programs offered to professionals from various rehabilitative disciplines (Physiotherapy, Occupational Therapy, Speech Therapy, Psychology, Special Education) to hone clinical skills with experts at NeuroGen.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels6 records
NeuroGen product offering
Product offeringCore offering
NeuroGen Brain & Spine Institute provides Neuro Regenerative Rehabilitation Therapy (NRRT), combining autologous bone marrow-derived cell therapy with comprehensive neurorehabilitation for patients with neurological disorders (autism, cerebral palsy, muscular dystrophy, spinal cord injury, stroke, head injury, motor neuron disease, intellectual disability). All treatment is delivered directly at its single facility in Navi Mumbai, India, with dedicated services for international patients from 70+ countries and an additional Regenerative Neuro-Rehabilitation Fellowship program for clinicians.
Product overview
NeuroGen Brain & Spine Institute operates as a single integrated medical facility offering regenerative medicine treatments for incurable neurological disorders. The core offering combines an innovative surgical procedure using autologous bone marrow tissue (after minimal manipulation) with comprehensive Neurorehabilitation Therapy, all delivered under one roof. The institute provides treatment services across multiple neurological conditions including Autism, Cerebral Palsy, Muscular Dystrophy, Spinal Cord Injury, Intellectual Disability, Brain Stroke, Head Injury, and Motor Neuron Disease/ALS. Additionally, the institute offers an educational Regenerative Neuro-Rehabilitation Fellowship program for healthcare professionals. Founded in 2008, the institute has treated over 16,000 patients from 100 countries with 112 scientific publications and 24 books to its credit.
Differentiator
Problem solved
Functional benefit
Brands
- Regenerative Neuro-Rehabilitation Fellowship: Neuro Regenerative Rehabilitation Fellowship program for professionals from physiotherapy, occupational therapy, speech therapy, psychology and special education disciplines
Products and services
- Regenerative Medicine / Stem Cell Therapy An innovative surgical procedure using autologous bone marrow tissue, after minimal manipulation, grafted by medical practitioners within the hospital in the same surgical sitting. Per Ministry of Health and Family Welfare directives under section 33P of the Drugs and Cosmetics Act, 1940, this procedure does not involve stem cells or stem cell-derived products. It is the regenerative medicine component delivered at NeuroGen's Navi Mumbai facility for patients with neurological disorders.
- Neurorehabilitation Therapy Comprehensive neurorehabilitation combining conventional tried-and-tested rehabilitation techniques with regenerative medicine to achieve better quality of life and functional outcomes for patients with neurological disorders, delivered at the Navi Mumbai facility.
- Autism Treatment Regenerative medicine and neurorehabilitation treatment for autism spectrum disorder, a neurodevelopmental disorder characterized by impaired social interaction, verbal and non-verbal communication deficits, and restricted and repetitive behaviors. Care typically begins in childhood, when parents first notice signs.
- Cerebral Palsy Treatment Treatment for cerebral palsy, a neurodevelopmental disorder caused by events leading to brain damage around the time of birth (nutritional factors, physical trauma, hypoxia, cord around the neck, birth asphyxia), ranging from mild physical disability to severe disability with comorbid intellectual disability.
- Muscular Dystrophy Treatment Treatment for muscular dystrophy, a genetic disorder causing progressive weakening of muscles leading to loss of walking and sitting ability, breathing difficulties, and eventual death. Includes forms such as limb girdle muscular dystrophy and Becker's muscular dystrophy, with reported outcomes including halted deterioration and improved physical abilities.
- Spinal Cord Injury Treatment Treatment for spinal cord injuries from trauma (road accidents, falls) or non-traumatic causes (spinal tumors, infections), potentially causing quadriplegia or paraplegia. Reported patient outcomes include significant independence improvement (e.g., 75% more independence reported by a treated patient).
- Intellectual Disability Treatment Treatment for intellectual disability (mental retardation), a generalized neurodevelopmental disorder characterized by significantly impaired intellectual and adaptive functioning, defined by an IQ score below 70 along with deficits in activities of daily routine. Reported outcomes include reduction in aggressive behavior, fewer tantrums, and improved attention, concentration, and behavioral patterns.
- Brain Stroke Treatment Treatment for brain stroke (cerebrovascular accident), a leading cause of disability that causes permanent damage to brain functions including inability to move limbs, vision problems, speech problems, altered sensations, and cognitive impairments.
- Head Injury / Traumatic Brain Injury Treatment Treatment for brain damage sustained due to trauma, leading to physical disability, loss of function, amnesia, and loss of cognitive function, often leaving permanent disability.
- Motor Neuron Disease / ALS Treatment Treatment for motor neuron diseases (MND) including Amyotrophic Lateral Sclerosis (ALS) — neurological disorders selectively affecting motor neurons that control voluntary muscle activity, including speaking, walking, swallowing, and general movement — causing increasing disability and eventual death.
- Regenerative Neuro-Rehabilitation Fellowship A fellowship program for professionals from rehabilitative disciplines — Physiotherapy, Occupational Therapy, Speech Therapy, Psychology, and Special Education — to hone clinical skills with experts at NeuroGen, including a clinical placement at the institute. Outreach and admissions are handled via [email protected].
Quantifiable outcome
- 7500+ patients treated from 100 countries (earlier figure mentioned on site)
- +4 more outcomes
Companies that use NeuroGen
Customer profileNamed customers6 records
Segments9 records
Ideal customer profiles3 records
NeuroGen technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
NeuroGen partnerships and signals
Strategic signalScale indicators5 records
Recent moves6 records
Expansion highlights5 records
NeuroGen competitors and assessment
Company assessmentDirect peers
- StemGenex: US-based regenerative medicine clinic marketing autologous stem cell treatments for neurological conditions. Direct peer in offering autologous cell therapies to neurological patient populations, though operating under a different regulatory regime.
- Beike Biotechnology: China-based provider of cell-based therapies for neurological and orthopedic conditions with a strong international patient pipeline. Closely comparable to NeuroGen's bone-marrow-derived cell therapy plus rehabilitation positioning and global medical-tourism focus.
- Regeneris Medical: US-based regenerative medicine provider offering autologous cell therapies for orthopedic and neurological conditions. Comparable to NeuroGen in autologous cell-based protocols targeting degenerative neurological indications.
- Global Stem Cells Group: International regenerative medicine company operating stem cell clinics and training programs across multiple geographies. Comparable as a multi-country cell therapy provider with physician training and medical-tourism patient acquisition.
Broad incumbents
- Shirley Ryan AbilityLab (formerly Rehabilitation Institute of Chicago): Leading US neurorehabilitation hospital and research center specializing in spinal cord injury, stroke, TBI and other neurological conditions. Comparable as a high-acuity neurorehabilitation destination with integrated research output, though without a cell-therapy component.
- Medanta - The Medicity: Leading Indian multi-super-specialty hospital with strong neurology, neurosurgery and rehabilitation offerings. Comparable in treating complex neurological patients in India but lacks NeuroGen's autologous cell-therapy specialization.
- Apollo Hospitals: Largest hospital chain in India offering multi-specialty tertiary care including neurosciences and rehabilitation. Comparable as an India-based destination for complex neurological treatment, but its scope is far broader and it does not specialize in cell therapy.
- Fortis Healthcare: Major Indian hospital chain with established neurology and rehabilitation programs. Comparable as a domestic Indian provider competing for the same neurological patient pool but operating within conventional (non-cell-therapy) medicine.
- Kessler Institute for Rehabilitation: Major US inpatient neurorehabilitation provider for stroke, brain injury and spinal cord injury. Comparable in patient population (SCI, TBI, stroke) but operates without a regenerative-medicine component, making it a benchmark for rehab outcomes rather than a cell-therapy competitor.
Emerging players
- Burzynski Clinic: US-based clinic offering alternative, non-mainstream treatments for cancer and neurological conditions, historically attracting international medical-tourism patients. Comparable in niche positioning, regulatory sensitivity and reliance on patient-driven demand, though its therapeutic modality is different.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
NeuroGen social profiles
Digital presenceNeuroGen compliance and trust
Trust signalCompliance4 records
NeuroGen financial estimates
Financial estimateRevenue estimate
Valuation estimate
NeuroGen leadership team
Management profileNumber of profiles
Profiles6 records
NeuroGen funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
NeuroGen M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about NeuroGen
What does NeuroGen do?
NeuroGen Brain & Spine Institute provides Neuro Regenerative Rehabilitation Therapy (NRRT), combining autologous bone marrow-derived cell therapy with comprehensive neurorehabilitation for patients with neurological disorders (autism, cerebral palsy, muscular dystrophy, spinal cord injury, stroke, head injury, motor neuron disease, intellectual disability). All treatment is delivered directly at its single facility in Navi Mumbai, India, with dedicated services for international patients from 70+ countries and an additional Regenerative Neuro-Rehabilitation Fellowship program for clinicians.
Is NeuroGen a public or private company?
NeuroGen is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was NeuroGen founded?
NeuroGen was founded in 2008. It employs 51 to 100 people.
Where is NeuroGen based?
NeuroGen is headquartered in Mumbai, India, in the Asia region.
How does NeuroGen make money?
Two revenue lines are on record. Patient Treatment Services are the primary driver. The others are fellowship Program.
Who are NeuroGen's main competitors?
Direct peers on record are StemGenex, Beike Biotechnology, Regeneris Medical and Global Stem Cells Group. Broad incumbents are Shirley Ryan AbilityLab (formerly Rehabilitation Institute of Chicago), Medanta - The Medicity, Apollo Hospitals, Fortis Healthcare and Kessler Institute for Rehabilitation. Burzynski Clinic is listed as an emerging player.
Does NeuroGen have an API?
No public API is recorded for NeuroGen.
What industry is NeuroGen in?
NeuroGen's product category is Neurological Rehabilitation Services. Its primary akta.pro industry code is HLAFAFAH, Neurorehabilitation Centers, with a secondary code of HLADAJAH, Neurologic Rehabilitation Centers (Stroke/TBI/SCI/MS/Parkinson’s). Its NAICS code is 621340 and its SIC code is 8000.